Dewpoint Therapeutics
Biotechnology ResearchView the employees at
Dewpoint Therapeutics-
Jian-Guo Ren Research Fellow at Dewpoint Therapeutics
-
Greater Boston
-
Top 10%
Hayley Smith Scrum Master and Software Developer-
Canada
-
Rising Star
-
Frankfurt, Hesse, Germany
-
Rising Star
Diana Mitrea Scientific Communications-
Greater Boston
-
Top 10%
Stephanie Robertson Director, R&D Program, Alliance & Operations Management-
Greater Boston
-
Top 5%
Overview
Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck, and Pfizer. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable.
-